264 related articles for article (PubMed ID: 31228489)
1. Effect of influenza H1N1 neuraminidase V116A and I117V mutations on NA activity and sensitivity to NA inhibitors.
Adams SE; Lee N; Lugovtsev VY; Kan A; Donnelly RP; Ilyushina NA
Antiviral Res; 2019 Sep; 169():104539. PubMed ID: 31228489
[TBL] [Abstract][Full Text] [Related]
2. Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets.
Ilyushina NA; Seiler JP; Rehg JE; Webster RG; Govorkova EA
PLoS Pathog; 2010 May; 6(5):e1000933. PubMed ID: 20523902
[TBL] [Abstract][Full Text] [Related]
3. Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.
Burnham AJ; Armstrong J; Lowen AC; Webster RG; Govorkova EA
J Virol; 2015 Apr; 89(8):4575-87. PubMed ID: 25673705
[TBL] [Abstract][Full Text] [Related]
4. Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.
Baek YH; Song MS; Lee EY; Kim YI; Kim EH; Park SJ; Park KJ; Kwon HI; Pascua PN; Lim GJ; Kim S; Yoon SW; Kim MH; Webby RJ; Choi YK
J Virol; 2015 Jan; 89(1):287-99. PubMed ID: 25320319
[TBL] [Abstract][Full Text] [Related]
5. Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.
Stoner TD; Krauss S; DuBois RM; Negovetich NJ; Stallknecht DE; Senne DA; Gramer MR; Swafford S; DeLiberto T; Govorkova EA; Webster RG
J Virol; 2010 Oct; 84(19):9800-9. PubMed ID: 20660186
[TBL] [Abstract][Full Text] [Related]
6. E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient.
L'Huillier AG; Abed Y; Petty TJ; Cordey S; Thomas Y; Bouhy X; Schibler M; Simon A; Chalandon Y; van Delden C; Zdobnov E; Boquete-Suter P; Boivin G; Kaiser L
J Infect Dis; 2015 Dec; 212(11):1726-34. PubMed ID: 25985905
[TBL] [Abstract][Full Text] [Related]
7. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
Okomo-Adhiambo M; Nguyen HT; Sleeman K; Sheu TG; Deyde VM; Garten RJ; Xu X; Shaw MW; Klimov AI; Gubareva LV
Antiviral Res; 2010 Feb; 85(2):381-8. PubMed ID: 19917319
[TBL] [Abstract][Full Text] [Related]
8.
Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
[TBL] [Abstract][Full Text] [Related]
9. An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness.
Kwon JJ; Choi WS; Jeong JH; Kim EH; Lee OJ; Yoon SW; Hwang J; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
J Gen Virol; 2018 Mar; 99(3):292-302. PubMed ID: 29493493
[TBL] [Abstract][Full Text] [Related]
10. [Impact of avian influenza virus H5N1 neuraminidase mutations on the activity of neuraminidase and the sensibility to neuraminidase inhibitors].
Chen Z; Zheng YH; Lin Y; Collins PJ; Hay AJ
Zhonghua Yi Xue Za Zhi; 2010 Jul; 90(27):1924-8. PubMed ID: 20979914
[TBL] [Abstract][Full Text] [Related]
11. Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level, and virulence of the 2009 pandemic influenza virus.
Pizzorno A; Abed Y; Bouhy X; Beaulieu E; Mallett C; Russell R; Boivin G
Antimicrob Agents Chemother; 2012 Mar; 56(3):1208-14. PubMed ID: 22203589
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
Gubareva LV; Trujillo AA; Okomo-Adhiambo M; Mishin VP; Deyde VM; Sleeman K; Nguyen HT; Sheu TG; Garten RJ; Shaw MW; Fry AM; Klimov AI
Antivir Ther; 2010; 15(8):1151-9. PubMed ID: 21149922
[TBL] [Abstract][Full Text] [Related]
13. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.
Choi WS; Jeong JH; Kwon JJ; Ahn SJ; Lloren KKS; Kwon HI; Chae HB; Hwang J; Kim MH; Kim CJ; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046464
[TBL] [Abstract][Full Text] [Related]
14. Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds.
Abed Y; Baz M; Boivin G
Antivir Ther; 2006; 11(8):971-6. PubMed ID: 17302366
[TBL] [Abstract][Full Text] [Related]
15. Neuraminidase inhibitors susceptibility profiles of highly pathogenic influenza A (H5N1) viruses isolated from avian species in India (2006-2015).
Sood R; Kumar N; Bhatia S; Chanu KV; Gupta CL; Pateriya AK; Mishra A; Khandia R; Mawale N; Singh VP
Antiviral Res; 2018 Oct; 158():143-146. PubMed ID: 30125616
[TBL] [Abstract][Full Text] [Related]
16. Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs.
Correia V; Santos LA; Gíria M; Almeida-Santos MM; Rebelo-de-Andrade H
J Med Virol; 2015 Jan; 87(1):45-56. PubMed ID: 25042157
[TBL] [Abstract][Full Text] [Related]
17. I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275Y.
LeGoff J; Rousset D; Abou-Jaoudé G; Scemla A; Ribaud P; Mercier-Delarue S; Caro V; Enouf V; Simon F; Molina JM; van der Werf S
PLoS One; 2012; 7(8):e37095. PubMed ID: 22936969
[TBL] [Abstract][Full Text] [Related]
18. Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.
Abed Y; Nehmé B; Baz M; Boivin G
Antiviral Res; 2008 Feb; 77(2):163-6. PubMed ID: 17919743
[TBL] [Abstract][Full Text] [Related]
19. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
[TBL] [Abstract][Full Text] [Related]
20. Novel genotyping and quantitative analysis of neuraminidase inhibitor resistance-associated mutations in influenza a viruses by single-nucleotide polymorphism analysis.
Duan S; Boltz DA; Li J; Oshansky CM; Marjuki H; Barman S; Webby RJ; Webster RG; Govorkova EA
Antimicrob Agents Chemother; 2011 Oct; 55(10):4718-27. PubMed ID: 21730113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
